Rheumacare Capsules, a joint pain drug, is recalling the medication over elevated lead levels, the FDA reports. Here’s a list ...

At least five state committees in the US are exploring ways to enact independent measures to improve drug affordability.

Supplements marketed to fight inflammation are everywhere. Do they actually work? Experts discuss the potential benefits and ...

The recalled lots are CAM040 and CALO79-N, according to the U.S. Food and Drug Administration. “In a test conducted by the Food and Drug Administration, the product has been found to contain lead at ...

Cedars-Sinai investigators may have figured out why certain immunosuppressive treatments don't work well in rheumatoid arthritis. In a study published in Science Immunology, scientists trace the ...

Rheumatoid arthritis (RA) remains a significant global health challenge, particularly in the context of biological therapy where the immune system’s response to therapeutic agents can critically ...

Big changes have come to Medicare’s prescription drug coverage, known as Part D, in 2026 that could affect how you pay for ...

Millions of Medicare Part D enrollees will see substantial out-of-pocket savings as negotiated drug prices take effect in ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much ...

FcRn blockers are approved for other indications: efgartigimod for adults with generalized myasthenia gravis and in ...